Uncaged Show

Prasen Shelar has spent most of his career around security teams.

Across Demisto, Palo Alto Networks, Fylamynt, and now Axari, he has seen the same thing over and over: security teams are expected to move incredibly fast, but so much of the work still depends on people manually holding everything together.

Figuring out what matters. Finding the right owner. Following up. Making decisions. Keeping things from getting dropped.

That’s the part of security Prasen has become obsessed with.
Before this, Prasen was the first PM at Demisto, worked on Cortex XSOAR and Prisma Cloud at Palo Alto Networks, and later helped build Fylamynt, which was acquired by NetApp.

Madelyn Sheldon is the Global Chief Commercial Officer at UTR Sports.

At Amazon, Madelyn led brand and product marketing for Prime, Alexa, and Amazon Devices, helping grow Prime from 30 million to more than 125 million U.S. members, taking Echo and Alexa from a nascent category to a household name, and directing nearly $1 billion in global marketing investment.

She also led Super Bowl campaigns that ranked #1 on the USA Today Ad Meter and earned an Emmy nomination.

In her marketing and commercial leadership roles at Tonal and UTR Sports, Madelyn carried full P&L responsibility: growing subscribers and recurring revenue, reducing churn, expanding internationally, launching and scaling new categories and services, and improving profitability across consumer, DTC, and platform businesses.

Sam is the Co-Founder, Senior Investor, and CEO of GuideTime, where he has the opportunity to work alongside his son, Danilo, and a great team building technology for the hospitality industry.
Their focus is pretty simple: Helping hotels, resorts, campgrounds, RV destinations, and other hospitality partners connect their guests with great local experiences, while helping the guides, outfitters, and small businesses behind those experiences reach more people.
Sam worked his way through college in hotels and restaurants and earned his Hospitality Management degree from Washington State University. One of his favorite jobs and memories in college was working as the Front Desk Manager at East Glacier Park Lodge in Montana. From there, he joined the Management Training Program at Westin Hotels.
His career eventually took him into enterprise technology, where he was fortunate to spend several decades working with some incredible people and organizations. That journey ultimately led him to IBM, with much of his work focused on digital transformation, Salesforce, AI, and customer experience.
Then, in 2020, Sam began helping Danilo build GuideTime. After retiring from IBM in 2026, he had the opportunity to join him as CEO shortly after and bring his hospitality roots and technology experience together in a completely different way.

Jeremy Fass is the Chief Revenue Officer at Intuizi and a solutions-driven commercial leader with a consistent track record of building and scaling revenue engines that create durable enterprise value.
An operator at heart, he builds from first principles, turns ambiguity into structure, and thrives at the intersection of data infrastructure, audience intelligence, and marketplace-driven models.
Throughout his nearly two-decade career, including foundational years scaling programmatic software at PubMatic and driving publisher solutions at Meta, Jeremy has focused on shifting high-growth tech companies from relational, early-stage operations to hyper-scaled commercial powerhouses.
He possesses a deep understanding of dual-sided marketplace dynamics, from supply and demand facilitation to complex liquidity design, and is most comfortable bringing velocity to "zero-to-two" environments.
At Intuizi, Jeremy is driving the company’s evolution into a dominant player in the AdTech and data intelligence sectors. He champions the use of AI-driven big data synthesis to help enterprises bypass the friction, stale data, and staggering costs of legacy "big box" infrastructure.
His goal is to help modern brands achieve true data interoperability, advanced outcome measurement, and sophisticated consumer journey personalization at scale—all rooted in a strict, uncompromised foundation of privacy compliance.

Dave Collins is the COO of BNI Global, the global leader in b2b networking and referrals with over $22 billion in closed referrals shared in the last year.

With 37 years in the real estate industry and senior leadership experience, David has built his career around one core belief: relationships drive revenue when they’re structured with discipline and intent.

Today, Dave helps lead global growth for BNI across 76 countries. His focus is simple, amplify the brand, strengthen chapters, and help business owners treat referrals as a system, not luck.

He believes BNI works best when it’s approached like a true marketing channel:
• Show up consistently
• Build real relationships
• Track performance
• Stay accountable

To Dave, BNI isn’t transactional. It’s transformational. He has seen firsthand how the right business community can change not only revenue outcomes, but leadership habits, confidence, and long-term vision.

Lizzy Livne is the founder and CEO of Quiet Lux, the modern concierge designed to make life lighter, smoother, and more beautiful. A military veteran who served in the Israel Defense Forces (IDF) and a Forbes 30 Under 30 honoree, Lizzy brings a rare blend of discipline, creativity, and strategic vision to everything she builds.

A graduate of Northeastern University, Lizzy previously held roles at Morgan Stanley, OTV, and Samsung Next, experiences that sharpened her operational expertise and deepened her understanding of how people and systems function at scale.

Quiet Lux specializes in the four pillars of modern living: life admin, life projects, lifestyle, and leisure. From managing calendars and handling logistics, to overseeing home projects, to curating travel, dining, and cultural experiences, Lizzy and her team bring structure and elegance to the everyday by ensuring clients have the space to focus on what truly matters to them.

Dr. Michael Weickert is a biopharmaceutical CEO, scientist, and author with more than 30 years of experience at the intersection of drug development, commercial strategy, and healthcare innovation. Throughout his career, he helped translate scientific discoveries into clinical programs and investor- and partner-ready products. That experience drives his work today: why do some breakthrough healthcare innovations never reach the patients who need them and what can we do about it?
As Chief Executive Officer of Pacylex Pharmaceuticals, Dr. Weickert has led the company’s strategic and financial direction, securing approximately $23 million in seed, Series A, and bridge financing and advancing multiple oncology programs to Phase 2 readiness, including achieving Orphan Drug and Fast Track designations for its lead asset. As CEO of Fe Pharmaceuticals, he has led a strategic transformation of the organization, strengthening executive leadership, expanding scientific advisory capabilities, securing early-stage funding and non-dilutive grants, and building successful collaborations with NIAID.
Across previous CEO and C-suite roles, Dr. Weickert has built and scaled biotechnology and medical technology organizations through critical stages of growth, including company formation, fundraising, clinical development, regulatory strategy, strategic partnerships, and commercialization. His career includes leadership roles at organizations such as Nektar Therapeutics, Ligand Pharmaceuticals, and other emerging life sciences companies, where he led cross-functional teams, advanced novel therapeutic programs, and helped bring scientific innovation closer to patient impact.
In addition to his executive leadership roles, Dr. Weickert serves as an advisor to Stanford University School of Medicine’s SPARK Translational Research Program, supporting researchers as they translate academic discoveries into practical therapeutics and diagnostics. Through his writing and public commentary, he examines the scientific, economic, and systemic forces that influence which medical breakthroughs reach patients—and which do not.

Following the eBook launch (One Network, One Truth), we have invited Michael Schlagel to talk about it broadly.

Michael Schlagel is the VP of Sales Americas Telecoms at VertiGIS, where he helps customers across various industries leverage the power of geographic information systems (GIS) to optimize their operations, enhance their decision-making, and improve their bottom line.

With over 20 years of professional sales experience and 8 years of sales management experience, Michael has a proven record of increasing sales volume and market share, while delivering exceptional customer satisfaction.

In this Uncaged, we had Remy Scalza and Caroline Carter-Smith as guets. Both are co-founders of CSuite Content, an executive communications firm I established in 2015.

This boutique agency works exclusively with CEOs and senior leaders on thought leadership and executive visibility — one of the first of its kind. Big companies find them when they’re ready to work with a highly specialized team of expert writers, thoughtful social media strategists, and trusted senior advisors who care intensely about results.

Before founding CSuite Content, Remy built his career as a journalist, contributing to publications including The Washington Post, The New York Times, and The Globe and Mail. After years of interviewing executives across a wide range of industries, he recognized that many accomplished leaders struggled to communicate their ideas in a way that reflected their expertise and differentiated them from their peers. That insight led him to establish CSuite Content, where he has spent the past decade helping leaders at fast-growing startups, Fortune 500 companies, and global enterprises develop thought leadership programs that support business growth, strengthen executive visibility, and drive meaningful media opportunities.

Before CSuite, Caroline worked in lifestyle and tech PR and spent time as a broadcast journalist, which gave her a low tolerance for jargon and a strong bias toward clarity. She is a compulsive strategist and always seeking out the most compelling narrative and story.

As a seasoned go-to-market strategist, Carol Ann is passionate about products that serve patients, alongside of exceptional marketing programs to deepen the human connection. She has had the privilege to serve in leadership roles for fortune 500 companies including Merck, Abbott, Johnson & Johnson, Bristol Myers-Squibb and LabCorp. -- Carol Ann has launched over 40 products and related HCP strategies across multiple markets including Pharma, Medical Devices, Diagnostics, Women's Health and the Cosmetics' industry.
She recently assumed the role of CEO and board member at PRP Concepts, a biologics company focused on regenerative medicine to heal chronic wounds, primarily diabetic foot ulcers. Their flagship product, Cascade is an autologous platelet system that uses the patients own plasma to create a fibrin membrane that acts as a vital scaffold, rich with the patients own growth factors to deliver sustained wound healing.